Clinical Trial: Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment of Immunocompromised Patients
Study Status: Completed
Recruit Status: RECRUITING
Condition: COVID-19 Convalescent Plasma Treatment
Study Type: OBSERVATIONAL
Official Title: Analysis of the Efficacy and Tolerance of Covid-19 Convalescent Plasma and Monoclonal Antibodies in the Treatment of SARS-Cov2 Infections in Immunocompromised Patients
Brief Summary:
Data on the use of convalescent plasma in the treatment of covid-19 are scarce: the results of randomized studies involving mainly immunocompetent patients are disappointing, while case series or retrospective data on more selected patients , in particular immunocompromised patients suggest a benefit in these patients whose clinical manifestation seems essentially related to the uncontrolled infection and not the cytokine storm.
Read more